Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Ann Neurol. 2016 Jun 1;80(1):59–70. doi: 10.1002/ana.24678

TABLE 1.

Summarized clinical features of patients with PYCR2 mutations

Clinical finding % of patients (of 14)

Microcephaly 100% (14/14)
Failure to thrive 100% (14/14)
Ecxessive vomiting 29% (4/14)
Facial findings
Typical facies: malar hypoplasia, upturned bulbous nose, low set prominent ears 100% (14/14)
Triangular face 86% (12/14)
Neurological findings
Global developmental delay 100% (14/14)
Intellectual disability 100% (14/14)
Upper motor neuron signs 100% (14/14)
Ataxia or absent gait 100% (14/14)
Hyperkinetic movements 100% (14/14)
Muscle atrophy 93% (13/14)
Seizures 57% (8/14)
Spasticity 57% (8/14)
Nystagmus 21% (3/14)
Brain imaging findings (of 13 patients)
Cortical atrophy 100% (13/13)
Thin corpus callosum 61% (8/13)